OXSQ

Oxford Square Capital Corp. (OXSQ) - Q1 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2026. Oxford Square Capital Corp. is a closed-end management investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). The Company's investment objective is to maximize total return by investing primarily in corporate debt securities and, to a lesser extent, Collateralized Loan Obligations (CLOs).

Key Financial Metrics

Material Changes vs. Prior Period

• Portfolio Valuation: The fair value of the investment portfolio decreased to $235.4 million from $251.7 million in the prior quarter. This decline was primarily driven by net realized losses of $30.7 million, largely attributable to a restructuring of a senior secured loan and the extinguishment of a CLO equity position.
• Realized Losses: Net realized losses increased significantly to $30.7 million in Q1 2026 compared to $12.2 million in Q1 2025.
• Investment Income: Total investment income decreased by approximately $1.2 million year-over-year, driven by lower interest income and reduced income from securitization vehicles.
• Expense Growth: Total expenses rose to $4.8 million from $4.1 million, primarily due to increased interest expense associated with the 7.75% Unsecured Notes issued in August 2025.
• Capital Activity: The Company raised approximately $12.3 million net of fees through its At-The-Market (ATM) program, issuing 7.2 million shares. No shares were repurchased under the authorized repurchase program.

Outlook, Risks, and Management Commentary

• Market Conditions: Management noted that U.S. loan market performance weakened in Q1 2026, with the Morningstar/LSTA US Leveraged Loan Index declining from 96.64% of par to 94.63% of par.
• Portfolio Composition: As of March 31, 2026, the portfolio consisted of 64.0% Senior Secured Notes, 30.7% CLO Equity, and 5.3% Equity/Other. The weighted average annualized yield on debt investments was approximately 14.74%.
• Credit Quality: The weighted average credit grade of the debt portfolio remained at 2.2. However, one debt investment (HealthChannels, Inc.) was placed on non-accrual status with a fair value of approximately $3.5 million.
• Liquidity: Cash and cash equivalents totaled $40.9 million. The Company maintains an asset coverage ratio of 177%, well above the 150% requirement under the 1940 Act.
• Risks: Key risks include interest rate volatility, the illiquidity of the portfolio (Level 3 assets), and the impact of leverage. The Company faces potential allocation constraints due to co-investment exemptive relief requirements with affiliated funds.
• Distributions: The Board declared quarterly distributions of $0.035 per share for the second and third quarters of 2026. The Q1 2026 distribution of $0.105 per share exceeded GAAP net investment income of $0.05 per share, indicating a portion may be a return of capital.

Investor Verification Checklist

• Verify the specific details and recovery prospects of the HealthChannels, Inc. investment currently on non-accrual status.
• Review the impact of the $30.7 million realized loss on the Company's capital base and future distribution sustainability.
• Monitor the 7.75% Unsecured Notes issued in August 2025 and their effect on the Company's cost of capital and net investment income.
• Assess the valuation methodology for CLO equity investments, which represent over 30% of the portfolio and are subject to significant unobservable inputs (Level 3).
• Confirm the tax characterization of distributions, as Q1 2026 distributions exceeded GAAP net investment income.